Bortezomib, thalidomide, and dexamethasone versus bortezomib, lenalidomide, and dexamethasone in transplant-eligible newly diagnosed multiple myeloma: a systemic review and meta-analysis
| Title: | Bortezomib, thalidomide, and dexamethasone versus bortezomib, lenalidomide, and dexamethasone in transplant-eligible newly diagnosed multiple myeloma: a systemic review and meta-analysis |
|---|---|
| Authors: | Wang, Yin-Che; Lin, Cheng-Hsien; Su, Yu-Chen; Teng, Chieh-Lin Jerry |
| Contributors: | TTY Biopharm |
| Source: | Hematology ; volume 30, issue 1 ; ISSN 1607-8454 |
| Publisher Information: | Informa UK Limited |
| Publication Year: | 2025 |
| Document Type: | article in journal/newspaper |
| Language: | English |
| DOI: | 10.1080/16078454.2025.2462249 |
| Availability: | https://doi.org/10.1080/16078454.2025.2462249; https://www.tandfonline.com/doi/pdf/10.1080/16078454.2025.2462249 |
| Rights: | http://creativecommons.org/licenses/by-nc/4.0/ |
| Accession Number: | edsbas.E3CE0AF1 |
| Database: | BASE |